Open AccessSelective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats
Author(s) -
Sang-Wan Seo,
Won Yong Jung,
Tai-Guang Piao,
Seung-Heon Hong,
Ki-Jung Yun,
Raekil Park,
Min-Kyo Shin,
HoJoon Song,
SungJoo Park
Publication year - 2007
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v13.i16.2298
Subject(s) - cholecystokinin , acute pancreatitis , medicine , endocrinology , proinflammatory cytokine , pancreatitis , dimethyl sulfoxide , chemistry , cyclooxygenase , enzyme , inflammation , biochemistry , receptor , organic chemistry
To investigate the effect of selective Cycloo-xygenase-2 (COX-2) inhibitor 4-[5-(4-Chloro-phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide (SC-236), on the cholecystokinin (CCK)-octapeptide-induced acute pancreatitis (AP) in rats.